STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Mar. 31, 2020

Stockholders' Equity Note [Abstract]

Schedule of Compensation Cost on Net Earnings

The Company’s results for the three months ended March 31, 2020 and 2019 reflected the following stock-based compensation cost, and such compensation cost had the following effects on net earnings:

	Increase/(Decrease) for the
	Three Months Ended March 31,
	2020		2019
Cost of sales	$	266	$	288
Operating expenses	1,915		1,343
Net earnings	(1,663)		(1,258)

Schedule of Stock Option Activity

Option activity for the three months ended March 31, 2020 and 2019 is summarized below:

For the three months ended March 31, 2020	Shares (000s)	Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2019	951	$	68.18	$	31,814
Granted	145	111.94
Exercised	(82)	54.39
Forfeited	(4)	89.90
Canceled	—	—
Outstanding as of March 31, 2020	1,010	$	75.48	$	25,399	6.7
Exercisable as of March 31, 2020	664	$	65.39	$	22,131	5.4

For the three months ended March 31, 2019	Shares (000s)	Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2018	887	$	61.59	$	16,192
Granted	185	84.19
Exercised	(7)	40.85
Forfeited	—	—
Canceled	—	—
Outstanding as of March 31, 2019	1,065	$	65.64	$	28,924	6.7
Exercisable as of March 31, 2019	685	$	56.91	$	24,588	5.4

Schedule of Other Information Pertaining to Stock Option Activity

Other information pertaining to option activity during the three months ended March 31, 2020 and 2019 was as follows:

	Three Months Ended March 31,
	2020		2019
Weighted-average fair value of options granted	$	23.05	$	18.26
Total intrinsic value of stock options exercised ($000s)	$	4,019	$	302

Schedule of Non-vested Restricted Stock Activity

Non-vested restricted stock activity for the three months ended March 31, 2020 and 2019 is summarized below:

	Three Months Ended March 31,
	2020			2019
	Shares (000s)	Weighted Average Grant Date Fair Value		Shares (000s)	Weighted Average Grant Date Fair Value
Non-vested balance as of December 31	138	$	80.03	79	$	72.75
Granted	34	111.44		66	84.27
Vested	(20)	67.43		(8)	58.52
Forfeited	(1)	86.82		—	—
Non-vested balance as of March 31	151	$	89.21	137	$	79.16

Schedule of Non-vested Performance Share Activity

Non-vested performance share activity for the three months ended March 31, 2020 and 2019 is summarized below:

	Three Months Ended March 31,
	2020			2019
	Shares (000s)	Weighted Average Grant Date Fair Value		Shares (000s)	Weighted Average Grant Date Fair Value
Non-vested balance as of December 31	70	$	81.26	53	$	75.61
Granted	20	126.46		33	81.79
Vested	(8)	104.15		(9)	65.64
Forfeited	(11)	82.71		(7)	60.85
Non-vested balance as of March 31	71	$	91.99	70	$	81.26